The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
SERES THERAPEUTICS INC | COM | 81750R102 | 57,327 | 12,682,876 | SH | DFND | 2 | 0 | 12,682,876 | 0 | |
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 17,849 | 3,204,437 | SH | DFND | 2 | 0 | 3,204,437 | 0 | |
QUANTERIX CORP | COM | 74766Q101 | 37,178 | 2,030,495 | SH | DFND | 0 | 2,030,495 | 0 | ||
DENALI THERAPEUTICS INC | COM | 24823R105 | 184,261 | 8,918,749 | SH | DFND | 1 | 0 | 8,918,749 | 0 | |
EVELO BIOSCIENCES INC | COM | 299734103 | 38,641 | 2,970,119 | SH | DFND | 2 | 0 | 2,970,119 | 0 | |
EVELO BIOSCIENCES INC | COM | 299734103 | 167,190 | 12,850,919 | SH | DFND | 1 | 0 | 12,850,919 | 0 | |
EVELO BIOSCIENCES INC | COM | 299734103 | 31,385 | 2,412,365 | SH | DFND | 0 | 2,412,365 | 0 | ||
RUBIUS THERAPEUTICS INC | COM | 78116T103 | 388,396 | 24,153,995 | SH | DFND | 2 | 0 | 24,153,995 | 0 | |
RUBIUS THERAPEUTICS INC | COM | 78116T103 | 186,188 | 11,578,828 | SH | DFND | 1 | 0 | 11,578,828 | 0 | |
RUBIUS THERAPEUTICS INC | COM | 78116T103 | 41,224 | 2,563,703 | SH | DFND | 0 | 2,563,703 | 0 | ||
MODERNA INC | COM | 60770K107 | 60 | 3,924 | SH | DFND | 0 | 3,924 | 0 | ||
MODERNA INC | COM | 60770K107 | 897,929 | 58,803,455 | SH | DFND | 2 | 0 | 58,803,455 | 0 |